BriefingIndustry newsIndustry briefingNEWSAbbVie and Anima partner for mRNA biology modulatorsAbbVie has collaborated with Anima Biotech for the discovery and development of mRNA biology modulators against three oncology and immunology targets.newsBlacksmith Medicines to merge with Forge TherapeuticsBlacksmith Medicines has signed a definitive merger agreement with Forge Therapeutics to create a combined entity to develop metalloenzyme-targeted drugsBriefingElement announces $200 Genome on benchtop sequencing systemElement Biosciences announced that a new throughput-based option for its AVITI System will provide sequencing on a benchtop for $200 a genomeIndustry newsIndustry briefing02/24/2024 13:23:11
Briefing
Element announces $200 Genome on benchtop sequencing system
Element Biosciences announced that a new throughput-based option for its AVITI System will provide sequencing on a benchtop for $200 a genome